Futura Medical due $5m milestone payment from Haleon
Futura Medical
33.45p
15:54 07/10/24
2.76%
0.90p
Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
FTSE 100
8,296.80
16:05 07/10/24
n/a
n/a
FTSE 350
4,575.06
16:05 07/10/24
n/a
n/a
FTSE AIM All-Share
738.23
16:05 07/10/24
n/a
n/a
FTSE All-Share
4,531.94
16:05 07/10/24
n/a
n/a
Haleon
376.10p
16:05 07/10/24
-2.72%
-10.50p
Pharmaceuticals & Biotechnology
22,213.86
16:05 07/10/24
0.48%
105.62
The AIM-traded firm said the milestone followed the successful distribution of online pre-orders and the availability of Eroxon in US retail stores.
It said the payment was expected to be received shortly.
Eroxon, Futura’s flagship product, is a clinically-proven sexual health product.
The milestone payment was another key step in its ongoing strategy to commercialise its products globally, with the US launch being a major milestone in the product’s growth.
At 1356 BST, shares in Futura Medical were up 2.77% at 33.45p.
Reporting by Josh White for Sharecast.com.